-
Je něco špatně v tomto záznamu ?
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
J. Stone, H. Fraser, AG. Lim, JG. Walker, Z. Ward, L. MacGregor, A. Trickey, S. Abbott, SA. Strathdee, D. Abramovitz, L. Maher, J. Iversen, J. Bruneau, G. Zang, RS. Garfein, YF. Yen, T. Azim, SH. Mehta, MJ. Milloy, ME. Hellard, R. Sacks-Davis,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, metaanalýza, Research Support, N.I.H., Extramural, práce podpořená grantem, systematický přehled
Grantová podpora
U01 DA036297
NIDA NIH HHS - United States
R01 DA024598
NIDA NIH HHS - United States
R01 DA030762
NIDA NIH HHS - United States
R01 DA031074
NIDA NIH HHS - United States
R01 DA029910
NIDA NIH HHS - United States
R01 DA033679
NIDA NIH HHS - United States
R01 DA043125
NIDA NIH HHS - United States
R21 DA042702
NIDA NIH HHS - United States
R37 DA019829
NIDA NIH HHS - United States
R01 DA041271
NIDA NIH HHS - United States
K24 DA017072
NIDA NIH HHS - United States
P30 AI036214
NIAID NIH HHS - United States
R01 DA012568
NIDA NIH HHS - United States
R01 DA033862
NIDA NIH HHS - United States
R01 DA037773
NIDA NIH HHS - United States
R21 DA041953
NIDA NIH HHS - United States
NLK
ProQuest Central
od 2001-08-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2001-08-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
- MeSH
- dospělí MeSH
- hepatitida C epidemiologie MeSH
- HIV infekce epidemiologie MeSH
- hodnocení rizik MeSH
- intravenózní abúzus drog komplikace MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- přenos infekční nemoci MeSH
- prevalence MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vězni * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- systematický přehled MeSH
- Geografické názvy
- Amerika MeSH
- Australasie MeSH
- Evropa MeSH
- jihovýchodní Asie MeSH
BACKGROUND: People who inject drugs (PWID) experience a high prevalence of incarceration and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after incarceration. We aimed to assess whether incarceration history elevates HIV or HCV acquisition risk among PWID. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, and PsycINFO databases for studies in any language published from Jan 1, 2000 until June 13, 2017 assessing HIV or HCV incidence among PWID. We included studies that measured HIV or HCV incidence among community-recruited PWID. We included only studies reporting original results and excluded studies that evaluated incident infections by self-report. We contacted authors of cohort studies that met the inclusion or exclusion criteria, but that did not report on the outcomes of interest, to request data. We extracted and pooled data from the included studies using random-effects meta-analyses to quantify the associations between recent (past 3, 6, or 12 months or since last follow-up) or past incarceration and HIV or HCV acquisition (primary infection or reinfection) risk among PWID. We assessed the risk of bias of included studies using the Newcastle-Ottawa Scale. Between-study heterogeneity was evaluated using the I2 statistic and the P-value for heterogeneity. FINDINGS: We included published results from 20 studies and unpublished results from 21 studies. These studies originated from Australasia, western and eastern Europe, North and Latin America, and east and southeast Asia. Recent incarceration was associated with an 81% (relative risk [RR] 1·81, 95% CI 1·40-2·34) increase in HIV acquisition risk, with moderate heterogeneity between studies (I2=63·5%; p=0·001), and a 62% (RR 1·62, 95% CI 1·28-2·05) increase in HCV acquisition risk, also with moderate heterogeneity between studies (I2=57·3%; p=0·002). Past incarceration was associated with a 25% increase in HIV (RR 1·25, 95% CI 0·94-1·65) and a 21% increase in HCV (1·21, 1·02-1·43) acquisition risk. INTERPRETATION: Incarceration is associated with substantial short-term increases in HIV and HCV acquisition risk among PWID and could be a significant driver of HCV and HIV transmission among PWID. These findings support the need for developing novel interventions to minimise the risk of HCV and HIV acquisition, including addressing structural risks associated with drug laws and excessive incarceration of PWID. FUNDING: Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institutes of Health.
Burnet Institute Melbourne VIC Australia
Center on Drug and Alcohol Research University of Kentucky KY USA
Centre hospitalier de l'Université de Montreal Montréal QC Canada
Department of Epidemiology and Preventive Medicine Monash University Melbourne VIC Australia
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA
Department of Epidemiology University of Kentucky College of Public Health KY USA
Department of Family Medicine Université de Montréal Montréal QC Canada
Department of Medicine University of Melbourne Melbourne VIC Australia
Faculty of Medicine and Health Sciences University of Sherbrooke Longueuil QC Canada
Faculty of Medicine Tbilisi State University Tbilisi Georgia
Faculty of Public Health and Policy London School of Hygiene and Tropical Medicine London UK
Health Protection Scotland National Health Service National Services Scotland Glasgow UK
Infectious Diseases AIDS and Clinical Immunology Research Center Tbilisi Georgia
International Charitable Foundation Alliance for Public Health Kiev Ukraine
James P Grant School of Public Health BRAC University Dhaka Bangladesh
National Infection Service Public Health England London UK
National Institute of Mental Health Klecany Czech Republic
National Institute of Public Health of Québec QC Canada
National Monitoring Centre for Drugs and Addiction Prague Czech Republic
Population Health Sciences Bristol Medical School University of Bristol Bristol UK
Public Health Institute Liverpool John Moores University Liverpool UK
School of Health and Life Sciences Glasgow Caledonian University Glasgow UK
Section of Infectious Diseases Taipei City Hospital Taipei City Government Taipei Taiwan
University Hospital Centre of Québec Research Centre Laval University QC Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034926
- 003
- CZ-PrNML
- 005
- 20191017093927.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1473-3099(18)30469-9 $2 doi
- 035 __
- $a (PubMed)30385157
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stone, Jack $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Electronic address: jack.stone@bristol.ac.uk.
- 245 10
- $a Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis / $c J. Stone, H. Fraser, AG. Lim, JG. Walker, Z. Ward, L. MacGregor, A. Trickey, S. Abbott, SA. Strathdee, D. Abramovitz, L. Maher, J. Iversen, J. Bruneau, G. Zang, RS. Garfein, YF. Yen, T. Azim, SH. Mehta, MJ. Milloy, ME. Hellard, R. Sacks-Davis, PM. Dietze, C. Aitken, M. Aladashvili, T. Tsertsvadze, V. Mravčík, M. Alary, E. Roy, P. Smyrnov, Y. Sazonova, AM. Young, JR. Havens, VD. Hope, M. Desai, E. Heinsbroek, SJ. Hutchinson, NE. Palmateer, A. McAuley, L. Platt, NK. Martin, FL. Altice, M. Hickman, P. Vickerman,
- 520 9_
- $a BACKGROUND: People who inject drugs (PWID) experience a high prevalence of incarceration and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after incarceration. We aimed to assess whether incarceration history elevates HIV or HCV acquisition risk among PWID. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, and PsycINFO databases for studies in any language published from Jan 1, 2000 until June 13, 2017 assessing HIV or HCV incidence among PWID. We included studies that measured HIV or HCV incidence among community-recruited PWID. We included only studies reporting original results and excluded studies that evaluated incident infections by self-report. We contacted authors of cohort studies that met the inclusion or exclusion criteria, but that did not report on the outcomes of interest, to request data. We extracted and pooled data from the included studies using random-effects meta-analyses to quantify the associations between recent (past 3, 6, or 12 months or since last follow-up) or past incarceration and HIV or HCV acquisition (primary infection or reinfection) risk among PWID. We assessed the risk of bias of included studies using the Newcastle-Ottawa Scale. Between-study heterogeneity was evaluated using the I2 statistic and the P-value for heterogeneity. FINDINGS: We included published results from 20 studies and unpublished results from 21 studies. These studies originated from Australasia, western and eastern Europe, North and Latin America, and east and southeast Asia. Recent incarceration was associated with an 81% (relative risk [RR] 1·81, 95% CI 1·40-2·34) increase in HIV acquisition risk, with moderate heterogeneity between studies (I2=63·5%; p=0·001), and a 62% (RR 1·62, 95% CI 1·28-2·05) increase in HCV acquisition risk, also with moderate heterogeneity between studies (I2=57·3%; p=0·002). Past incarceration was associated with a 25% increase in HIV (RR 1·25, 95% CI 0·94-1·65) and a 21% increase in HCV (1·21, 1·02-1·43) acquisition risk. INTERPRETATION: Incarceration is associated with substantial short-term increases in HIV and HCV acquisition risk among PWID and could be a significant driver of HCV and HIV transmission among PWID. These findings support the need for developing novel interventions to minimise the risk of HCV and HIV acquisition, including addressing structural risks associated with drug laws and excessive incarceration of PWID. FUNDING: Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institutes of Health.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a přenos infekční nemoci $7 D018562
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a HIV infekce $x epidemiologie $7 D015658
- 650 _2
- $a hepatitida C $x epidemiologie $7 D006526
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prevalence $7 D015995
- 650 12
- $a vězni $7 D011329
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a intravenózní abúzus drog $x komplikace $7 D015819
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Amerika $x epidemiologie $7 D000569
- 651 _2
- $a jihovýchodní Asie $x epidemiologie $7 D001210
- 651 _2
- $a Australasie $x epidemiologie $7 D044362
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Fraser, Hannah $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Lim, Aaron G $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Walker, Josephine G $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Ward, Zoe $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a MacGregor, Louis $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Trickey, Adam $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Abbott, Sam $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Strathdee, Steffanie A $u Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
- 700 1_
- $a Abramovitz, Daniela $u Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
- 700 1_
- $a Maher, Lisa $u Kirby Institute for Infection and Immunity, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
- 700 1_
- $a Iversen, Jenny $u Kirby Institute for Infection and Immunity, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
- 700 1_
- $a Bruneau, Julie $u Department of Family Medicine, Université de Montréal, Montréal, QC, Canada; Centre hospitalier de l'Université de Montreal, Montréal, QC, Canada.
- 700 1_
- $a Zang, Geng $u Centre hospitalier de l'Université de Montreal, Montréal, QC, Canada.
- 700 1_
- $a Garfein, Richard S $u Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
- 700 1_
- $a Yen, Yung-Fen $u Section of Infectious Diseases, Taipei City Hospital, Taipei City Government, Taipei, Taiwan.
- 700 1_
- $a Azim, Tasnim $u James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
- 700 1_
- $a Mehta, Shruti H $u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- 700 1_
- $a Milloy, Michael-John $u BC Centre for Excellence in HIV/AIDS and Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- 700 1_
- $a Hellard, Margaret E $u Burnet Institute, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
- 700 1_
- $a Sacks-Davis, Rachel $u Burnet Institute, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
- 700 1_
- $a Dietze, Paul M $u Burnet Institute, Melbourne, VIC, Australia.
- 700 1_
- $a Aitken, Campbell $u Burnet Institute, Melbourne, VIC, Australia.
- 700 1_
- $a Aladashvili, Malvina $u Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
- 700 1_
- $a Tsertsvadze, Tengiz $u Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; Faculty of Medicine, Tbilisi State University, Tbilisi, Georgia.
- 700 1_
- $a Mravčík, Viktor $u National Monitoring Centre for Drugs and Addiction, Prague, Czech Republic; Department of Addictology, The First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic; National Institute of Mental Health, Klecany, Czech Republic.
- 700 1_
- $a Alary, Michel $u University Hospital Centre of Québec Research Centre-Laval University, QC, Canada; National Institute of Public Health of Québec, QC, Canada.
- 700 1_
- $a Roy, Elise $u National Institute of Public Health of Québec, QC, Canada; Faculty of Medicine and Health Sciences, University of Sherbrooke, Longueuil, QC, Canada.
- 700 1_
- $a Smyrnov, Pavlo $u International Charitable Foundation Alliance for Public Health, Kiev, Ukraine.
- 700 1_
- $a Sazonova, Yana $u International Charitable Foundation Alliance for Public Health, Kiev, Ukraine.
- 700 1_
- $a Young, April M $u Department of Epidemiology, University of Kentucky College of Public Health, KY, USA; Center on Drug and Alcohol Research, University of Kentucky, KY, USA.
- 700 1_
- $a Havens, Jennifer R $u Center on Drug and Alcohol Research, University of Kentucky, KY, USA.
- 700 1_
- $a Hope, Vivian D $u Public Health Institute, Liverpool John Moores University, Liverpool, UK; National Infection Service, Public Health England, London, UK.
- 700 1_
- $a Desai, Monica $u National Infection Service, Public Health England, London, UK.
- 700 1_
- $a Heinsbroek, Ellen $u National Infection Service, Public Health England, London, UK.
- 700 1_
- $a Hutchinson, Sharon J $u School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, National Health Service National Services Scotland, Glasgow, UK.
- 700 1_
- $a Palmateer, Norah E $u School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, National Health Service National Services Scotland, Glasgow, UK.
- 700 1_
- $a McAuley, Andrew $u School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
- 700 1_
- $a Platt, Lucy $u Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
- 700 1_
- $a Martin, Natasha K $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
- 700 1_
- $a Altice, Frederick L $u Yale School of Medicine, Department of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
- 700 1_
- $a Hickman, Matthew $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 700 1_
- $a Vickerman, Peter $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- 773 0_
- $w MED00006437 $t The Lancet. Infectious diseases $x 1474-4457 $g Roč. 18, č. 12 (2018), s. 1397-1409
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30385157 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191017094355 $b ABA008
- 999 __
- $a ok $b bmc $g 1451586 $s 1073476
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 18 $c 12 $d 1397-1409 $e 20181029 $i 1474-4457 $m Lancet. Infectious diseases $n Lancet Infect Dis $x MED00006437
- GRA __
- $a U01 DA036297 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA024598 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA030762 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA031074 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA029910 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA033679 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA043125 $p NIDA NIH HHS $2 United States
- GRA __
- $a R21 DA042702 $p NIDA NIH HHS $2 United States
- GRA __
- $a R37 DA019829 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA041271 $p NIDA NIH HHS $2 United States
- GRA __
- $a K24 DA017072 $p NIDA NIH HHS $2 United States
- GRA __
- $a P30 AI036214 $p NIAID NIH HHS $2 United States
- GRA __
- $a R01 DA012568 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA033862 $p NIDA NIH HHS $2 United States
- GRA __
- $a R01 DA037773 $p NIDA NIH HHS $2 United States
- GRA __
- $a R21 DA041953 $p NIDA NIH HHS $2 United States
- LZP __
- $a Pubmed-20191007
